S L Nightingale1. Show Affiliations » 1. Office of Health Affairs, FDA, Rockville, MD 20857.
Abstract
Mesh： See more » Cholesterol/bloodConsumer Product SafetyDrug-Related Side Effects and Adverse ReactionsEquipment and Supplies/adverse effectsHumansIndoles/therapeutic useMigraine Disorders/drug therapyReagent Kits, DiagnosticSulfonamides/therapeutic useSumatriptanUnited StatesUnited States Food and Drug Administration
Substances： See more » IndolesReagent Kits, DiagnosticSulfonamidesSumatriptanCholesterol
Year: 1993 PMID： 8384667 DOI： 10.1001/jama.269.14.1776
Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272